Product Code: ETC340835 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pneumonia vaccine market in Australia remains crucial for public health, with government immunization programs playing a significant role in driving demand. The aging population and increased awareness of respiratory diseases have led to higher vaccine uptake, particularly among vulnerable groups such as children and the elderly. Continuous research and development efforts are introducing more effective conjugate and polysaccharide vaccines. However, supply chain challenges and vaccine hesitancy pose hurdles to market expansion.
The Australian pneumonia vaccine market is fueled by ongoing government immunization programs and public health awareness campaigns. An aging population and the high burden of respiratory diseases increase the need for preventive healthcare solutions. Research and development in vaccine technologies, coupled with support from global health organizations, contribute to market expansion.
The pneumonia vaccine market in Australia faces regulatory hurdles and high research and development costs, which limit the entry of new players. Variability in vaccine uptake, influenced by public awareness and government immunization policies, also creates market uncertainty. Moreover, logistical challenges in vaccine distribution, particularly in remote areas, affect accessibility.
The demand for pneumonia vaccines in Australia is increasing due to rising awareness about respiratory health and government immunization programs. Investment opportunities exist in vaccine research, expansion of cold chain logistics for efficient distribution, and partnerships with healthcare providers for improved accessibility and coverage.
The pneumonia vaccine market is governed by pharmaceutical regulations and public health policies. The government ensures strict safety and efficacy standards for pneumonia vaccines through the Therapeutic Goods Administration (TGA). Import restrictions regulate foreign vaccine supplies, while domestic research funding supports vaccine development and immunization programs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pneumonia Vaccine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Australia Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Australia Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Australia Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Australia Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Australia Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia |
4.2.2 Growing elderly population in Australia, who are at higher risk of contracting pneumonia |
4.2.3 Government initiatives to promote vaccination programs and reduce the burden of pneumonia |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines, limiting accessibility to certain demographic groups |
4.3.2 Limited availability of healthcare infrastructure in remote areas, hindering vaccine distribution and administration |
5 Australia Pneumonia Vaccine Market Trends |
6 Australia Pneumonia Vaccine Market, By Types |
6.1 Australia Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 Australia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 Australia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Australia Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Australia Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Australia Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Australia Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Australia Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Australia Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Australia Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Australia Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Australia Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Australia Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Australia Pneumonia Vaccine Market Export to Major Countries |
7.2 Australia Pneumonia Vaccine Market Imports from Major Countries |
8 Australia Pneumonia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate for pneumonia vaccine in target population groups |
8.2 Number of pneumonia cases reported annually in Australia |
8.3 Rate of hospitalizations due to pneumonia in different age groups |
9 Australia Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Australia Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Australia Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Australia Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Australia Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Pneumonia Vaccine Market - Competitive Landscape |
10.1 Australia Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Australia Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |